Steroid hormones and Women's health in the postmenopausal age

Description of the granted funding

The population in the Western world is aging. In Finland, there are over 1,2 million women in the postmenopausal age, about 25% of them are using postmenopausal hormone therapy (HT). The risk-benefit profile of HT is under continuous debate. The focus of this research program is in aging women's health, particularly with regard to cardiovascular disease and breast cancer, because these are the most common health problems in the postmenopausal age. Our interest is specifically in adipose tissue steroid hormone metabolism. Adipose tissue acts as a steroid hormone reservoir and may synthesize active hormones in response to different stimuli, such as inflammation, obesity or postmenopausal HT. The mechanisms linking these entities are incompletely known. In our epidemiological and clinical studies we study the risks for cardiovascular diseases and breast cancer among women using or stopping postmenopausal HT. These data will provide new information to help clinical decision-making.
Show more

Starting year

2020

End year

2024

Granted funding

Hanna M Savolainen-Peltonen Orcid -palvelun logo
189 369 €

Funder

Research Council of Finland

Funding instrument

Targeted Academy projects

Other information

Funding decision number

333983

Research fields

Kliiniset lääketieteet

Identified topics

public health, occupational health